Navigation Links
Joslin Diabetes Center Convenes Leaders in Diabetes Prevention, Treatment, Payment, Education and Research at Diabetes Innovation 2012
Date:7/18/2012

BOSTON, July 18, 2012 /PRNewswire/ -- The diabetes epidemic demands a powerful response from leaders in the diabetes community, nationally and globally.  To this end, for the first time in its 114 year history, Joslin Diabetes Center, an affiliate of Harvard Medical School will convene all stakeholders for  a groundbreaking, immersive activity over 3 days in September called  Diabetes Innovation 2012 (September 23-25, 2012 at the Hyatt Crystal City in Arlington, VA). 

Diabetes Innovation 2012 will act as a powerful catalyst for ideas, partnerships and collaborations. It will provoke thought, innovation and action that address the cost, productivity and quality-of-life impact of diabetes on our society by bringing together all stakeholders:  payers, purchasers, providers, industry, government, research, patients, consumers, technologists, developers, and funders. 

"Simply put, we MUST forge new approaches and dramatically increase our sense of urgency to address diabetes head-on.  Despite all of our collective efforts, we are not keeping up with the global threats presented by obesity and diabetes," says John L. Brooks III, CEO, Joslin Diabetes Center. "To effectively make a real difference, we need to convene, apply our collective energies, and work together, to truly create innovative policies and programs that will involve all stakeholders and that will make a real difference.  This world-wide pandemic will not be solved until all of us use our combined resources, commitment, determination, and passion to map out an aggressive and meaningful path forward."

Diabetes Innovation 2012 will provide a powerful foundation for sustained advancement in all facets of diabetes prevention, treatment and payment reforms including social media and gaming, translational research breakthroughs, food sourcing, distribution to mobile patient technologies and everything in between. 

"Diabetes is the seventh leading cause of death in the U.S.  We need more preventive programs that help improve individuals' health and sustain behavior change.  When consumers make better choices about diet, exercise and smoking, potentially disastrous outcomes like diabetes and heart disease can be avoided," said Donald M. Berwick, MD, former CMS Administrator and former President and CEO, Institute for Healthcare Improvement and Diabetes Innovation 2012 Senior Advisor. "We need to 'innovate' processes, tools and incentives towards prevention for consumers and all stakeholders."

Diabetes Innovation 2012 features leaders and innovators from all sectors, and will include innovations in prevention, delivery and adherence as well as innovations in process and policy.  Among over 80 faculty, and hundreds of audience members, from industry and the payer, provider and purchaser community and academia, leaders from many of the most important government agencies (AHRQ, PCORI, NIH, CDC, FDA, CMS, CMMI) will be on hand to encourage open dialogue and collaboration to speed system improvements.

Support for the activity is provided by Sanofi US.  According to Dennis Urbaniak, Vice President, Head of U.S. Diabetes, Sanofi US, "At Sanofi, we know innovation is the key to fostering accelerated improvements. We are pleased to provide opportunities that stimulate innovation not only in products, but also in other solutions, as evidenced by our Data Design Diabetes Innovation Challenge. We're committed to supporting Joslin Diabetes Center's important initiative to convene all stakeholders onto common ground, to move forward as collaborators, and not as individual constituencies."

"Our very successful pilot of this convening event that we held in Washington DC last July, convinced us that there is a tremendous amount of interest and enthusiasm for expanding  this program to a three day program so we can engage as many participants and encompass as many ideas and inputs as possible," according to Brooks. "If you really want to shape the future direction of diabetes, covering the entire spectrum of care, education, technology, prevention as well as the landscape of diabetes complications, comorbidities, and related health conditions, you should sign up now so your voice can be heard."

To sponsor, exhibit or register for Diabetes Innovation 2012, please visit www.diabetesinnovation.org.

About Joslin Diabetes Center

Joslin Diabetes Center is the world leader in diabetes research, clinical care and education.   Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure.  Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.  Our mission is to prevent, treat and cure diabetes.  Our vision is a world free of diabetes and its complications.  For more information, visit www.joslin.org.


'/>"/>
SOURCE Joslin Diabetes Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Whats Next In Vaccines (Malaria, Diabetes, Alzheimers, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
2. Tethys Bioscience and Lose it! Announce a Strategic Partnership to Support Diabetes Prevention
3. Lilly Diabetes Announces Once Upon A Time Contest Winner
4. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
5. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
6. Frost & Sullivan: Launch of New Classes of Oral Antidiabetic Drugs by 2014 will Uplift Prospects for the European Diabetes Therapeutics Market
7. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
8. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
9. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
10. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
11. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... 23, 2016  Guerbet announced today that it has ... Horizon Award . One of 12 suppliers ... for its support of Premier members through exceptional local ... and commitment to lower costs. ... of our outstanding customer service from Premier," says ...
Breaking Medicine Technology:
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):